Latest preclinical data from ASGCT 2026 suggest

Codexis presented advances at TIDES USA 2026 in B

Scribe Therapeutics has secured clearance from th

Cognition Therapeutics completed a planned meetin

BioCardia presented preliminary open-label result

Commercial multi-modal screening pathways launch

The AI-powered nutrition clinic is betting that

New research from Beacon Biosignals explores how

New global report suggests the sector’s next c

HAYA Therapeutics announced that the first cohort

Eisai outlined new and expanded clinical data for

Capsida Biotherapeutics has closed its synrgy Pha

Oligomerix, Inc.

Trinity Capital committed $50 million in growth c

GlycanAge and Circulate Health announced the publ

New Longevity Show blog explores why gyms and he

LW-1017 enters human trials with a new strategy

Sky Labs’ CART ring has secured UK medical app

New industry ranking suggests longevity has move

Vir Biotechnology will present complete Week 96 d

Sunrise has received FDA clearance for Sunrise Ai

Cyclana Bio has received Health Research Authorit

Scribe Therapeutics presented preclinical data at

New trial results suggest gut bacteria could hel

As immunosenescence drives systemic disease, ban

A new partnership aims to answer a big question

Listeria-based immunotherapy enters first human

New research suggests a blood-based aging marker

AstraZeneca’s BAXFENDY (baxdrostat) has receive

Beacon Biosignals’ neuroscience team will parti

AstraZeneca and Roche Diagnostics Asia Pacific ha

At the American Thoracic Society 2026 meeting, In

JCR Pharmaceuticals presented preclinical data at

New clinical data suggests oxidized cholesterol

Cerevance’s Phase 3 milestone and fresh fundin

New partnership links diabetes and heart care in

Could temporary nutrient scarcity help regenerat

Arrowhead on 5 May 2026 granted Madrigal an exclu

Cambridge-derived startup raises $730k (£550k)

4D Molecular Therapeutics reported first-quarter

Fractyl Health received European approval to begi

Sky Labs has completed medical device registratio

Ahead of The Longevity Show, Poonam Desai discus

Can we finally treat joint pain without trading

As body composition scans move into the longevity

Buck Institute researchers link APOE2 longevity

An FDA backing signals growing momentum for RNA-

Resolution Therapeutics will present new preclini

NeuroVision announced the acquisition of Durin Li

HepaRegeniX announced that an abstract reporting